Transplantation of Mesenchymal Stem Cells Overexpressing Fibroblast Growth Factor 21 Facilitates Cognitive Recovery and Enhances Neurogenesis in a Mouse Model of Traumatic Brain Injury
Restricted accessResearch articleFirst published online January, 2020
Transplantation of Mesenchymal Stem Cells Overexpressing Fibroblast Growth Factor 21 Facilitates Cognitive Recovery and Enhances Neurogenesis in a Mouse Model of Traumatic Brain Injury
Traumatic brain injury (TBI) is a progressive and complex pathological condition that results in multiple adverse consequences, including impaired learning and memory. Transplantation of mesenchymal stem cells (MSCs) has produced limited benefits in experimental TBI models. Fibroblast growth factor 21 (FGF21) is a novel metabolic regulator that has neuroprotective effects, promotes remyelination, enhances angiogenesis, and elongates astrocytic processes. In this study, MSCs were genetically engineered to overexpress FGF21 in order to improve their efficacy in TBI. MSCs overexpressing FGF21 (MSC-FGF21) were transplanted to mouse brain by intracerebroventricular injection 24 h after TBI was induced by controlled cortical impact (CCI). Hippocampus-dependent spatial learning and memory, assessed by the Morris water maze test, was markedly decreased 3–4 weeks after TBI, a deficit that was robustly recovered by treatment with MSC-FGF21, but not MSC-mCherry control. Hippocampus-independent learning and memory, assessed by the novel object recognition test, was also impaired; these effects were blocked by treatment with both MSC-FGF21 and MSC-mCherry control. FGF21 protein levels in the ipsilateral hippocampus were drastically reduced 4 weeks post-TBI, a loss that was restored by treatment with MSC-FGF21, but not MSC-mCherry. MSC-FGF21 treatment also partially restored TBI-induced deficits in neurogenesis and maturation of immature hippocampal neurons, whereas MSC-mCherry was less effective. Finally, MSC-FGF21 treatment also normalized TBI-induced impairments in dendritic arborization of hippocampal neurons. Taken together, the results indicate that MSC-FGF21 treatment significantly improved TBI-induced spatial memory deficits, impaired hippocampal neurogenesis, and abnormal dendritic morphology. Future clinical investigations using MSC-FGF21 to improve post-TBI outcomes are warranted.
Get full access to this article
View all access options for this article.
References
1.
MurrayC.J., and LopezA.D. (1997). Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet, 349, 1269–1276.
2.
HyderA.A., WunderlichC.A., PuvanachandraP., GururajG., and KobusingyeO.C. (2007). The impact of traumatic brain injuries: a global perspective. NeuroRehabilitation, 22, 341–353.
3.
WaljasM., IversonG.L., LangeR.T., HakulinenU., DastidarP., HuhtalaH., LiimatainenS., HartikainenK., and OhmanJ. (2015). A prospective biopsychosocial study of the persistent post-concussion symptoms following mild traumatic brain injury. J. Neurotrauma, 32, 534–547.
4.
RabinowitzA.R. and LevinH.S. (2014). Cognitive sequelae of traumatic brain injury. Psychiatr. Clin. North Am. 37, 1–11.
5.
McAllisterT.W., FlashmanL.A., McDonaldB.C., and SaykinA.J. (2006). Mechanisms of working memory dysfunction after mild and moderate TBI: evidence from functional MRI and neurogenetics. J. Neurotrauma, 23, 1450–1467.
6.
JohanssonB., BerglundP., and RonnbackL. (2009). Mental fatigue and impaired information processing after mild and moderate traumatic brain injury. Brain Inj. 23, 1027–1040.
7.
HenningerN., DutzmannS., SicardK.M., KollmarR., BardutzkyJ., and SchwabS. (2005). Impaired spatial learning in a novel rat model of mild cerebral concussion injury. Exp. Neurol. 195, 447–457.
8.
PalaciosE.M., Sala-LlonchR., JunqueC., Fernandez-EspejoD., RoigT., TormosJ.M., BargalloN., and VendrellP. (2013). Long-term declarative memory deficits in diffuse TBI: correlations with cortical thickness, white matter integrity and hippocampal volume. Cortex, 49, 646–657.
9.
LiY., and ChoppM. (2009). Marrow stromal cell transplantation in stroke and traumatic brain injury. Neurosci. Lett. 456, 120–123.
10.
AertkerB.M., BediS., and CoxC.S.Jr. (2016). Strategies for CNS repair following TBI. Exp. Neurol. 275, Pt. 3, 411–426.
11.
MahmoodA., LuD., and ChoppM. (2004). Intravenous administration of marrow stromal cells (MSCs) increases the expression of growth factors in rat brain after traumatic brain injury. J. Neurotrauma, 21, 33–39.
12.
XiongY., MahmoodA., and ChoppM. (2010). Angiogenesis, neurogenesis and brain recovery of function following injury. Curr. Opin. Investig. Drugs, 11, 298–308.
13.
WalkerP.A., ShahS.K., HartingM.T., and CoxC.S.Jr. (2009). Progenitor cell therapies for traumatic brain injury: barriers and opportunities in translation. Dis. Model Mech. 2, 23–38.
14.
WeiL., FraserJ.L., LuZ.Y., HuX., and YuS.P. (2012). Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and neurogenesis after cerebral ischemia in rats. Neurobiol. Dis. 46, 635–645.
15.
GoldE.M., SuD., Lopez-VelazquezL., HausD.L., PerezH., LacuestaG.A., AndersonA.J., and CummingsB.J. (2013). Functional assessment of long-term deficits in rodent models of traumatic brain injury. Regen. Med. 8, 483–516.
16.
XuY., HuX., WangL., JiangZ., LiuX., YuH., ZhangZ., ChenH., ChenH., SteinhoffG., LiJ., and Jian'anW. (2013). Preconditioning via angiotensin type 2 receptor activation improves therapeutic efficacy of bone marrow mononuclear cells for cardiac repair. PLoS One, 8, e82997.
17.
SakataH., NiizumaK., YoshiokaH., KimG.S., JungJ.E., KatsuM., NarasimhanP., MaierC.M., NishiyamaY., and ChanP.H. (2012). Minocycline-preconditioned neural stem cells enhance neuroprotection after ischemic stroke in rats. J. Neurosci. 32, 3462–3473.
18.
SunX., FangB., ZhaoX., ZhangG., and MaH. (2014). Preconditioning of mesenchymal stem cells by sevoflurane to improve their therapeutic potential. PLoS One, 9, e90667.
19.
TsaiL.K., WangZ., MunasingheJ., LengY., LeedsP., and ChuangD.M. (2011). Mesenchymal stem cells primed with valproate and lithium robustly migrate to infarcted regions and facilitate recovery in a stroke model. Stroke, 42, 2932–2939.
20.
LinaresG.R., ChiuC.T., ScheuingL., LengY., LiaoH.M., MaricD., and ChuangD.M. (2016). Preconditioning mesenchymal stem cells with the mood stabilizers lithium and valproic acid enhances therapeutic efficacy in a mouse model of Huntington's disease. Exp. Neurol. 281, 81–92.
21.
TsaiL.K., LengY., WangZ., LeedsP., and ChuangD.M. (2010). The mood stabilizers valproic acid and lithium enhance mesenchymal stem cell migration via distinct mechanisms. Neuropsychopharmacology, 35, 2225–2237.
22.
LengY., WangZ., TsaiL.K., LeedsP., FesslerE.B., WangJ., and ChuangD.M. (2015). FGF-21, a novel metabolic regulator, has a robust neuroprotective role and is markedly elevated in neurons by mood stabilizers. Mol. Psychiatry, 20, 215–223.
23.
InagakiT., LinV.Y., GoetzR., MohammadiM., MangelsdorfD.J., and KliewerS.A. (2008). Inhibition of growth hormone signaling by the fasting-induced hormone FGF21. Cell Metab. 8, 77–83.
24.
LengY., WangJ., WangZ., LiaoH.M., WeiM., LeedsP., and ChuangD.M. (2016). Valproic acid and other HDAC inhibitors upregulate FGF21 gene expression and promote process elongation in glia by inhibiting HDAC2 and 3. Int. J. Neuropsychopharmacol. 19, pyw035.
25.
WangZ., LengY., WangJ., LiaoH.M., BergmanJ., LeedsP., KozikowskiA., and ChuangD.M. (2016). Tubastatin A, an HDAC6 inhibitor, alleviates stroke-induced brain infarction and functional deficits: potential roles of alpha-tubulin acetylation and FGF-21 up-regulation. Sci. Rep. 6, 19626.
26.
YuF., WangZ., TchantchouF., ChiuC.T., ZhangY., and ChuangD.M. (2012). Lithium ameliorates neurodegeneration, suppresses neuroinflammation, and improves behavioral performance in a mouse model of traumatic brain injury. J. Neurotrauma, 29, 362–374.
27.
MorrisR. (1984). Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods, 11, 47–60.
28.
LaiJ.H., KarlssonT.E., WuJ.C., HuangC.Z., ChenY.H., KangS.J., BrodinA.T.S., HofferB.J., OlsonL., ChiangY.H., and ChenK.Y. (2019). Role of Nogo receptor-1 for recovery of balance, cognition, and emotion after mild traumatic brain injury in mice. J. Neurotrauma, 36, 1054–1059.
29.
CzurkoA., CzehB., SeressL., NadelL., and BuresJ. (1997). Severe spatial navigation deficit in the Morris water maze after single high dose of neonatal x-ray irradiation in the rat. Proc. Natl. Acad. Sci. U. S. A. 94, 2766–2771.
30.
ScherbelU., RaghupathiR., NakamuraM., SaatmanK.E., TrojanowskiJ.Q., NeugebauerE., MarinoM.W., and McIntoshT.K. (1999). Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injury. Proc. Natl. Acad. Sci. U. S. A. 96, 8721–8726.
31.
VorheesC.V., and WilliamsM.T. (2006). Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat. Protoc. 1, 848–858.
32.
BarkerG.R., BirdF., AlexanderV., and WarburtonE.C. (2007). Recognition memory for objects, place, and temporal order: a disconnection analysis of the role of the medial prefrontal cortex and perirhinal cortex. J. Neurosci. 27, 2948–2957.
33.
BarkerG.R., and WarburtonE.C. (2011). When is the hippocampus involved in recognition memory?. J. Neurosci. 31, 10721–10731.
34.
GradyM.S., CharlestonJ.S., MarisD., WitgenB.M., and LifshitzJ. (2003). Neuronal and glial cell number in the hippocampus after experimental traumatic brain injury: analysis by stereological estimation. J. Neurotrauma, 20, 929–941.
35.
GaoX., Deng-BryantY., ChoW., CarricoK.M., HallE.D., and ChenJ. (2008). Selective death of newborn neurons in hippocampal dentate gyrus following moderate experimental traumatic brain injury. J. Neurosci. Res. 86, 2258–2270.
36.
BrownJ.P., Couillard-DespresS., Cooper-KuhnC.M., WinklerJ., AignerL., and KuhnH.G. (2003). Transient expression of doublecortin during adult neurogenesis. J. Comp. Neurol. 467, 1–10.
37.
VillasanaL.E., KimK.N., WestbrookG.L., and SchnellE. (2015). Functional integration of adult-born hippocampal neurons after traumatic brain injury(1,2,3). eNeuro, 2, ENEURO.0056-15.2015.
38.
NivF., KeinerS., Krishna, WitteO.W., LieD.C., and RedeckerC. (2012). Aberrant neurogenesis after stroke: a retroviral cell labeling study. Stroke, 43, 2468–2475.
39.
JessbergerS., ZhaoC., ToniN., ClemensonG.D.Jr., LiY., and GageF.H. (2007). Seizure-associated, aberrant neurogenesis in adult rats characterized with retrovirus-mediated cell labeling. J. Neurosci. 27, 9400–9407.
40.
WhyteJ., PolanskyM., CavallucciC., FlemingM., LhulierJ., and CoslettH.B. (1996). Inattentive behavior after traumatic brain injury. J. Int. Neuropsychol. Soc. 2, 274–281.
41.
McAllisterT.W., FlashmanL.A., SparlingM.B., and SaykinA.J. (2004). Working memory deficits after traumatic brain injury: catecholaminergic mechanisms and prospects for treatment—a review. Brain Inj. 18, 331–350.
42.
MathiasJ.L., and MansfieldK.M. (2005). Prospective and declarative memory problems following moderate and severe traumatic brain injury. Brain Inj. 19, 271–282.
43.
Serra-GrabulosaJ.M., JunqueC., VergerK., Salgado-PinedaP., ManeruC., and MercaderJ.M. (2005). Cerebral correlates of declarative memory dysfunctions in early traumatic brain injury. J. Neurol. Neurosurg. Psychiatry, 76, 129–131.
44.
VukovicJ., BorlikovaG.G., RuitenbergM.J., RobinsonG.J., SullivanR.K., WalkerT.L., and BartlettP.F. (2013). Immature doublecortin-positive hippocampal neurons are important for learning but not for remembering. J. Neurosci. 33, 6603–6613.
45.
ChildK.M., HerrickD.B., SchwobJ.E., HolbrookE.H., and JangW. (2018). The neuroregenerative capacity of olfactory stem cells is not limitless: implications for aging. J. Neurosci. 38, 6806–6824.
46.
DonegaV., NijboerC.H., van VelthovenC.T., YoussefS.A., de BruinA., van BelF., KavelaarsA., and HeijnenC.J. (2015). Assessment of long-term safety and efficacy of intranasal mesenchymal stem cell treatment for neonatal brain injury in the mouse. Pediatr. Res. 78, 520–526.
47.
MishraS.K., RanaP., KhushuS., and GangenahalliG. (2017). Therapeutic prospective of infused allogenic cultured mesenchymal stem cells in traumatic brain injury mice: a longitudinal proton magnetic resonance spectroscopy assessment. Stem Cells Transl. Med. 6, 316–329.
48.
GoodM.A., BarnesP., StaalV., McGregorA., and HoneyR.C. (2007). Context- but not familiarity-dependent forms of object recognition are impaired following excitotoxic hippocampal lesions in rats. Behav. Neurosci. 121, 218–223.
49.
LangstonR.F., and WoodE.R. (2010). Associative recognition and the hippocampus: differential effects of hippocampal lesions on object-place, object-context and object-place-context memory. Hippocampus, 20, 1139–1153.
50.
MumbyD.G., and PinelJ.P. (1994). Rhinal cortex lesions and object recognition in rats. Behav. Neurosci. 108, 11–18.
51.
EnnaceurA., NeaveN., and AggletonJ.P. (1996). Neurotoxic lesions of the perirhinal cortex do not mimic the behavioural effects of fornix transection in the rat. Behav. Brain Res. 80, 9–25.
52.
BusseyT.J., MuirJ.L., and AggletonJ.P. (1999). Functionally dissociating aspects of event memory: the effects of combined perirhinal and postrhinal cortex lesions on object and place memory in the rat. J. Neurosci. 19, 495–502.
53.
NormanG., and EacottM.J. (2004). Impaired object recognition with increasing levels of feature ambiguity in rats with perirhinal cortex lesions. Behav. Brain Res. 148, 79–91.
54.
BadmanM.K., PissiosP., KennedyA.R., KoukosG., FlierJ.S., and Maratos-FlierE. (2007). Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab. 5, 426–437.
55.
GalmanC., LundasenT., KharitonenkovA., BinaH.A., ErikssonM., HafstromI., DahlinM., AmarkP., AngelinB., and RudlingM. (2008). The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man. Cell Metab. 8, 169–174.
56.
MakelaJ., TselykhT.V., MaioranaF., ErikssonO., DoH.T., MudoG., KorhonenL.T., BelluardoN., and LindholmD. (2014). Fibroblast growth factor-21 enhances mitochondrial functions and increases the activity of PGC-1alpha in human dopaminergic neurons via Sirtuin-1. Springerplus, 3, 2.
57.
InagakiT., DutchakP., ZhaoG., DingX., GautronL., ParameswaraV., LiY., GoetzR., MohammadiM., EsserV., ElmquistJ.K., GerardR.D., BurgessS.C., HammerR.E., MangelsdorfD.J., and KliewerS.A. (2007). Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab. 5, 415–425.
58.
OwenB.M., BookoutA.L., DingX., LinV.Y., AtkinS.D., GautronL., KliewerS.A., and MangelsdorfD.J. (2013). FGF21 contributes to neuroendocrine control of female reproduction. Nat. Med. 19, 1153–1156.
59.
KopenG.C., ProckopD.J., and PhinneyD.G. (1999). Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc. Natl. Acad. Sci. U. S. A. 96, 10711–10716.
60.
WangS., KanQ., SunY., HanR., ZhangG., PengT., and JiaY. (2013). Caveolin-1 regulates neural differentiation of rat bone mesenchymal stem cells into neurons by modulating Notch signaling. Int. J. Dev. Neurosci. 31, 30–35.
61.
ChirumamillaS., SunD., BullockM.R., and ColelloR.J. (2002). Traumatic brain injury induced cell proliferation in the adult mammalian central nervous system. J. Neurotrauma, 19, 693–703.
62.
RiceA.C., KhaldiA., HarveyH.B., SalmanN.J., WhiteF., FillmoreH., and BullockM.R. (2003). Proliferation and neuronal differentiation of mitotically active cells following traumatic brain injury. Exp. Neurol. 183, 406–417.
63.
RamaswamyS., GoingsG.E., SoderstromK.E., SzeleF.G., and KozlowskiD.A. (2005). Cellular proliferation and migration following a controlled cortical impact in the mouse. Brain Res. 1053, 38–53.
64.
IbrahimS., HuW., WangX., GaoX., HeC., and ChenJ. (2016). Traumatic brain injury causes aberrant migration of adult-born neurons in the hippocampus. Sci. Rep. 6, 21793.
65.
ChenJ., HuJ., LiuH., XiongY., ZouY., HuangW., ShaoM., WuJ., YuL., WangX., WangX., and LinL. (2018). FGF21 protects the blood-brain barrier by upregulating PPARgamma via FGFR1/beta-klotho after traumatic brain injury. J. Neurotrauma, 35, 2091–2103.
66.
KurodaM., MuramatsuR., MaederaN., KoyamaY., HamaguchiM., FujimuraH., YoshidaM., KonishiM., ItohN., MochizukiH., and YamashitaT. (2017). Peripherally derived FGF21 promotes remyelination in the central nervous system. J. Clin. Invest. 127, 3496–3509.
67.
XuJ., StanislausS., ChinookoswongN., LauY.Y., HagerT., PatelJ., GeH., WeiszmannJ., LuS.C., GrahamM., BusbyJ., HechtR., LiY.S., LiY., LindbergR., and VeniantM.M. (2009). Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models—association with liver and adipose tissue effects. Am. J. Physiol. Endocrinol. Metab. 297, E1105–E1114.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
